OACC.US Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

Financial Services Health Care Providers & Services USA Stocks
10.70 USD
Close of Nov 17, 2026
10.50 10.93
Market cap
USD 142M
P/E
38.2x
P/B
1.33x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is OACC.US undervalued?

Graham number
Price10.70
Graham value7.12
Premium50.3%

OACC.US trades 50.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share fundamental analysis

No fundamental analysis for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share yet.

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered i…

Full company profile